Adecoagro S.A. (ADGO)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 16,130.00 |
|---|---|
| 52-week range | 10,400.00 – 23,500.00 |
| Return, 1 month / 3 months | −7.8% / −9.0% |
| Return, 1 year / 3 years | +36.2% / −18.6% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 52.9% |
| Worst drawdown (1 year) | -38.6% |
| Average daily value traded | 373.12M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Adecoagro is an agricultural and agro-industrial company based in Argentina that farms land and processes crops in South America. It grows grains such as soybeans, corn and wheat, produces sugar and ethanol from sugarcane, and runs rice and dairy operations. The company also manages farmland and livestock. Its customers include food processors, commodity traders and fuel markets, and its operations are spread across Argentina, Brazil and Uruguay.
On this site Adecoagro S.A. appears as a stock on the Buenos Aires Exchange (Argentina), code ADGO, with prices in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Adecoagro S.A. (ADGO) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 16,130.00 on 22 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 99 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 36.2% and over the last three months it fell 9.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.5% | ||
| From 52-week high | -29.0% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.0% | ||
| 6-month return | -19.1% | ||
| 12-month return, skipping the last month | 47.8% | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 52.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.6% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 373.12M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −7.8% |
| 3 months | −9.0% |
| 6 months | −19.1% |
| 1 year | +36.2% |
| 3 years | −18.6% |
| 5 years | +532.0% |
Signals
| 50-day / 200-day average | 17,247.20 / 16,723.22 |
|---|---|
| Golden / death cross (60 days) | Golden, 41 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 675.48 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 May 2026 | EUR 184.0242 |
| 3 Nov 2025 | EUR 265.3349 |
| 30 Apr 2025 | EUR 265.5625 |
| 12 Nov 2024 | EUR 264.0708 |
| 13 May 2024 | EUR 255.2435 |
| 8 Nov 2023 | EUR 500.3683 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.